Literature DB >> 3714732

Tumor heterogeneity in metastasis.

G Heppner, K Yamashina, B Miller, F Miller.   

Abstract

Mesh:

Substances:

Year:  1986        PMID: 3714732

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


× No keyword cloud information.
  6 in total

1.  Understanding metastatic SCCHN cells from unique genotypes to phenotypes with the aid of an animal model and DNA microarray analysis.

Authors:  Xin Zhang; Ling Su; Ali A Pirani; Haiyan Wu; Hongzheng Zhang; Dong M Shin; Kim M Gernert; Zhuo Georgia Chen
Journal:  Clin Exp Metastasis       Date:  2006-09-22       Impact factor: 5.150

2.  Tumor heterogeneity in neoplasms of breast, colon, and skin.

Authors:  Jian Li; Kai Wang; Thomas Dyrsø Jensen; Shengting Li; Lars Bolund; Carsten Wiuf
Journal:  BMC Res Notes       Date:  2010-11-25

3.  Sorafenib controls the epithelial‑mesenchymal transition of ovarian cancer cells via EGF and the CD44‑HA signaling pathway in a cell type‑dependent manner.

Authors:  Ga Bin Park; Hyun-Suk Ko; Daejin Kim
Journal:  Mol Med Rep       Date:  2017-06-14       Impact factor: 2.952

4.  Estimation of tumor heterogeneity using CGH array data.

Authors:  Kai Wang; Jian Li; Shengting Li; Lars Bolund; Carsten Wiuf
Journal:  BMC Bioinformatics       Date:  2009-01-09       Impact factor: 3.169

5.  The cancer stem cell concept in progression of head and neck cancer.

Authors:  Zhuo Georgia Chen
Journal:  J Oncol       Date:  2009-12-03       Impact factor: 4.375

6.  A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment.

Authors:  Linnea La Fleur; Ann-Charlotte Johansson; Karin Roberg
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.